Skip to main content

Table 1 Patients demographics and operative characteristics

From: Effect of topical ropivacaine on the response to endotracheal tube during emergence from general anesthesia: a prospective randomized double-blind controlled study

 

Group C

Group R

P

Age (years)

46.54 ± 12.93

49.54 ± 11.99

0.390

Gender:Male/Female

7/19

6/20

0.749

ASA classification (I/II)

7/19

9/17

0.548

Height (cm)

164.31 ± 6.20

165.08 ± 6.37

0.661

Weight (kg)

62.65 ± 10.74

66.38 ± 0.96

0.221

Operation time(min)

88.35 ± 36.46

104.54 ± 46.43

0.168

Anesthesia time (min)

107.42 ± 39.90

122.92 ± 48.52

0.214

  1. Categorical variables were presented as numbers and percentage, quantitative variables were shown as means and standard deviation. ASA American Society of Anesthesiologists. Group R: the patients were recieved 6 ml of 0.75% ropivacaine for throat, glottic area and tracheal mucosa uniform spray; Group C: the patients were recieved with 6 ml of saline for throat, glottic area and tracheal mucosa uniform spray as control